Hester Biosciences shares gains 20% after joining hands with IIT Guwahati for COVID-19 vaccine


Published On: Wednesday, April 29, 2020 | By:

Hester Biosciences shares gains 20% after joining hands with IIT Guwahati for COVID-19 vaccine

Shares of Hester Biosciences hit the upper circuit of 20 % on Wednesday’s trade after joining hands with Indian Institute of Technology Guwahati to work on the vaccine development against Covid-19. The agreement between the two parties was signed on April 15, 2020. They expect the coronavirus vaccine to be ready by the end year to start animal studies. The work is currently in its early stage of development. The vaccine will be based on a recombinant avian paramyxovirus based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2. The recombinant avian paramyxovirus-1 expressing the SARS-CoV-2 protein could be used as a vaccine candidate for further study, it added.IITG and Hester have collaborated to develop and manufacture a recombinant vaccine against Covid-19 disease as a preventive measure. Hester’s involvement would be from master seed development up to release of the commercial vaccine”.

We are on Telegram!

Telegram Logo

JOIN our telegram channel to receive updates on Financial News and Stock and FNO Tips.

Click Here!

Follow Us On: